NUPLAZID
NDC 63090-340, pimavanserin tartrate, capsule, from Acadia Pharmaceuticals Inc..
- Product NDC
- 63090-340
- Status
- Listed
- Labeler
- Acadia Pharmaceuticals Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA210793
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63090-340 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PIMAVANSERIN TARTRATE34 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63090-340-30 | 63090034030 | 30 CAPSULE in 1 BOTTLE, PLASTIC (63090-340-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1e6bea44-57d6-4bac-9328-46e1ee59f83bNADAC price for package 63090034030
GET /v1/drugs/nadac/63090034030
Use it
Look up 63090-340 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63090-340 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63090-340. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.